ABSTRACT
INTRODUCTION
Connective tissue grafts (CTGs) are used successfully in periodontology for root coverage procedures in cases of gingival recession and to increase gingival thickness. 1 Soft-tissue (STi) augmentation procedures around dental implants are performed mainly to improve esthetic outcomes. After immediate implant placement and physiological STi remodeling, disturbances caused by healing or implant abutments, as well as immoderate labial or buccal positioning of dental implants, can lead to mucosal recession. 2 The peri-implant mucosa should be augmented to prevent or treat mucosal recession. [3] [4] [5] The enhancement of soft-tissue thickness (STTh) around dental implants may also be required to avoid shimmering through implant parts, especially those made of titanium. 6 Particularly, in the esthetic zone, CTGs have become the first-line therapy. 7 As part of therapy involving immediate implant placement and provisionalization, CTGs have also been shown to increase STTh and stabilize the peri-implant mucosa in thin biotypes. 8 In a previous investigation, the use of a monolayer collagen matrix (mCM) for STi augmentation increased
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STTh in the context of submerged healing for 6 months after surgery. 9 The outcome of mCM use was comparable to that of treatment with CTGs. The aim of the present study was to investigate the possible use of the same mCM for peri-implant mucosal thickening at the time of immediate implant placement and loading.
MATERIALS AND METHODS
Patients
This was a prospective, nonrandomized, and private practice-based study. It included patients who presented for extraction of fractured or otherwise nonsalvageable teeth between September 2012 and April 2015. The inclusion criteria were: (a) Absence of pregnancy, diabetes mellitus, and history of medication or drug abuse; (b) smoking <10 cigarettes per day; (c) need to extract one maxillary anterior tooth (canine to canine) with adjacent dentition present; (d) presence of the buccal bone plate in the extraction socket (as determined during surgery); (e) good oral health; and (f) presence of an adequate amount of bone to accommodate a cylindrical screw-type implant with a minimum dimension of 3.5 × 11.5 mm. This study was conducted in accordance with the Helsinki Declaration of 1975, as revised in 2000. The patients were given a full description of the treatment procedures and then given at least 1 week to submit a signed informed consent form.
Treatment
At least 6 weeks before surgery, oral hygiene instruction, tooth cleaning and polishing, and subgingival scaling were performed. 10 The same surgeon (Gregor-Georg Zafiropoulos) performed all surgeries. Target tooth extraction was performed atraumatically, and implants were placed manually at 875 rpm and 35 Ncm torque (Dentegris, Duisburg, Germany) using a one-stage surgical approach. The gaps were augmented with bovine xenograft (Cerabone, Botiss Biomaterials, Berlin, Germany; Fig. 1A ). Split-thickness flaps (STFs) were created on the buccal side, and porcine mCMs (Mucoderm, Botiss Biomaterials, Berlin, Germany; 1.7 mm thickness; approved for STi augmentation in Europe [CE 0483]) were used for augmentation. The mCMs were hydrated in sterile saline solution for 10 min, trimmed, and positioned on the periosteum.
According to our surgical protocol, the patients received one of the two alternative flap designs. In group I, an envelope STF was created, the mCM was covered coronally, the flap was fixed with a horizontal mattress suture using nonresorbable suture, and subsequently, the mCM was fixed with the mucosal flap with simple loop suture ( Impressions were taken using a polyether material (Impregum; 3M ESPE, St. Paul, MN, USA) and the open-tray impression technique. Subsequently, healing abutments were positioned on the implants until the delivery of temporary fixed partial dentures (tFPDs) 2 days later (Fig. 3A) . The tFPDs were fixed on customized milled titanium abutments (ZenoTi, grade V, Type IV; Wieland, Pforzheim, Germany) using provisional cement (TempBond; Kavo Kerr Group, Charlotte, NC, USA). 6 months after surgery (T1), tFPDs were replaced by metal-ceramic fused FPDs, fixed using provisional cement (Improv; Alvelogro Inc., Snoqualmie, WA, USA; Figs 3B and C; and 4A to C). The patients were prescribed a chlorhexidine mouth rinse (0.1% Chlorhexamed Fluid; GlaxoSmithKline, Buehl, Germany) twice daily for 2 weeks, and sutures were removed at 2 weeks postoperatively. A soft diet was recommended for 4 weeks following surgery. Oral hygiene control and tooth polishing were performed for every 3 weeks from the time of suture removal until T1.
Measurement and Evaluation
Standardized STTh measurements were taken preoperatively (T0, immediately after extraction; Fig. 1A ) and at T1 (Figs 5A and B) using a customized metal stent (CrCo alloy), which overlay the surgical area at a distance of 8 to 10 mm. The stent had one hole positioned 3 mm below the buccal crest of the extraction socket. Using light pressure, an endodontic reamer (#15; Dentsply DeTrey, Konstanz, Germany) with a silicone disk stop was inserted through the hole perpendicularly through the mucosal surface to the cortical bone. The stop was then placed in tight contact with the STi surface and fixated with cyanoacrylate. After careful removal of the stent with the reamer in place, penetration depth was measured to the nearest 0.1 mm using a gauge.
The implants were evaluated at T1 according to the success criteria of Smith and Zarb. 10 Peri-implant radiolucency, mobility, pain, discomfort, and/or neurosensory alteration were considered to indicate implant failure. For the evaluation of hard-tissue and STi augmentation, cone beam computed tomography (CBCT) was 
Data Analysis
Statistical analyses were performed using commercial software (Statistical Package for the Social Sciences, version 23; Deutschland GmbH, Ehningen, Germany). Mean values, standard deviations (SDs), and median values of STTh at T0 and T1 were calculated. The normality of distributions was examined using KolmogorovSmirnov test. Matrix thickness loss (MThL) and changes in STTh were also determined. The MThL was calculated in the following manner: STTh T0 + mCM thicknessSTTh T1. Differences between groups I and II in MThL and STTh at T0 and T1 were examined using MannWhitney U-test, with a statistically significance level of p < 0.05. Differences between STTh at T0 and STTh at T1 were examined in the same manner. Associations of STTh at T0 with the change in STTh and MThL were examined using Kendall's tau correlation analysis.
RESULTS
A total of 27 patients (14 males and 13 females; mean age, 52.2 ± 12.9 [range: 25-72] years) were included in this study and they underwent ST augmentation (Table 1 ). All patients demonstrated good oral hygiene and compliance (probing pocket depth: 4.2 ± 0.7 mm; clinical attachment level: 6 ± 0.2 mm; bleeding on probing: 6%; and plaque index: 8%). The indications for extraction and distribution of teeth extracted and implants placed are shown in Tables 2 and 3 respectively. Patients' age, but not sex or smoking habit, differed statistically significantly between treatment groups (p = 0.007; Table 1 ). All healing periods were uneventful. The augmented areas showed no sign of inflammation or other indication of wound healing disturbance, and no implant was lost.
No statistically significant difference in STTh change or MThL was observed between groups I and II (p > 0.05, Table 4 ). The STTh at T0 and T1 differed statistically significantly in the whole population and in both groups (all p < 0.001). In the total population, the mean MThL was detected at 1.0 ± 0.2 mm (median: 1.1 mm; Table 4 ).
The CBCT showed no sign of buccal bone plate resorption (Fig. 5C ). Kendall's tau values for the correlation of STTh with STTh change and MThL at T0 were −0.392 and 0.434 respectively (Graphs 1A and B). 
DISCUSSION
In the current study, mCM was used as grafting material for STi augmentation at the time of immediate implant placement. Two different surgical techniques were used for mucosal flap elevation. To the best of our knowledge, the present report is the first to describe mCM use for this purpose. The postoperative healing period and 6-month followup period were uneventful, with no complication, implant loss, or inflammation. 6 months after the surgery, STTh had increased, independent of flap procedure. These results are comparable to the outcomes of previous study in which mCM was used with submerged healing; Zafiropoulos et al 9 observed mean STTh increases of 1.06 mm at 1 mm below the gingival margin and 0.89 mm at 3 mm below the gingival margin. The latter value is mostly comparable to the results of the current study, in which STTh was measured 3 mm below the buccal crest.
The outcomes of the current study were inferior to those of peri-implant STi augmentation using CTGs in other studies, which resulted in STi gains of 0.83 mm 11,12 at 9 months postoperatively, and 0.97 13 and 1.3 mm 14 at 12 months postoperatively. Given the similarity of findings in both treatment groups and the small number of cases in each group, correlation analysis was applied to the total population in this study. STTh at T0 was not correlated with STTh change or MThL. Although this study was not designed to investigate the influence of biotype on STTh, initial STTh seems to have no influence on the clinical outcome. In this study, a membrane with a standardized thickness of 1.7 mm was used. In further studies, the use of different mCM thicknesses for different tissue biotypes might be advantageous, improving the technique and clarifying the indications.
In this study, mean MThL was comparable in both groups. The mean STTh change in both groups was 0.7 mm, which corresponds to the remaining thickness of the native membrane. This thickness is slightly greater than that observed in previous studies of STi augmentation with CTGs around teeth (0.5 mm). The thickness of harvested CTGs is typically 1 to 1.5 mm.
14-17 Thus, loss of nearly 50 to 70% of the initial CTG thickness occurs during the healing period due to remodeling. [16] [17] [18] [19] In this study, the proportions of STTh loss in groups I and II were 64.7% and 58.8% respectively, in accordance with the results observed with CTG use. 15, 16, 18, 20 Over an observation period of 6 months, mCM use thus seems to yield results equivalent to CTG use. In STi augmentation using CTGs, the most STTh loss occurs within the first 6 months; after this period of integration and remodeling, STTh remains constant for up to 30 months. 16 Further research is needed to determine whether long-term results are similar for mCM use. 
